← FDA Drug Approvals (Drugs@FDA)

CABAZITAXEL

NDA · New Drug Application · Sponsor: ACCORD HLTHCARE · Approved 2021-12-29

Drug application

FDA Application #

NDA207949

Application type

New Drug Application

Brand name

CABAZITAXEL

Generic name

Cabazitaxel

Active ingredients

CABAZITAXEL

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

ACCORD HLTHCARE

First approval

2021-12-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown